European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

11:11 AM EDT, 10/21/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were climbing higher late Wednesday morning, rising 0.73% to 1,913.39 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and biopharmaceutical company Cellectis (CLLS), which advanced 4.6% and 5% respectively. They were followed by medical device maker EDAP TMS (FOCL) and semiconductor company Sequans Communications (SQNS), which rose 3.3% and 1.2% respectively. The decliners from continental Europe were led by telecommunications company Ericsson (ERIC) and internet browser company Opera (OPRA), which fell 1.9% and 0.9% respectively. They were followed by consumer goods company Unilever (UL) and pharmaceutical company Novo Nordisk (NVO), which were off 0.9% and 0.3% respectively. The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which increased 3.5% and 3.3% respectively. They were followed by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Mereo BioPharma Group (MREO), which were up 1.8% and 3.2% respectively. The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB), which dropped 2.9%. It was followed by pharmaceutical company GSK (GSK) and communications company WPP (WPP), which lost 1.2% and 0.7% respectively.